Respiratory Effectiveness Group
The Respiratory Effectiveness Group (REG) is a not-for-profit initiative established by international experts in real-life and comparative effectiveness research in respiratory medicine.
The Group sets quality standards in the field of real-life research and improves understanding of the optimum role of real-life data to inform meaningful clinical practice guidelines, drug licensing and post-marketing surveillance processes and improved patient care.
Latest News
New REG Newsletter
New REG Newsletter Catch up with the latest REG news and happenings in our March 2021 Newsletter ...
Read More
Read More
New REG Publication – A real-life comparative effectiveness study in asthma exacerbations in primary care
A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care A ...
Read More
Read More
New REG Publication in Real Life COPD
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life In patients with COPD ...
Read More
Read More